Trial: 202010193

INTREPId (INTermediate Risk Erection PreservatIon Trial): A Randomized Phase II Trial of Radiation Therapy and Darolutamide for Prostate Cancer

Phase

II

Principal Investigator

Michalski, Jeff

Disease Site

Prostate

Learn more about this study at: clinicaltrials.gov